Literature DB >> 3262326

The use and misuse of upper gastrointestinal endoscopy.

K L Kahn1, J Kosecoff, M R Chassin, D H Solomon, R H Brook.   

Abstract

STUDY
OBJECTIVE: To determine how appropriately physicians in 1981 did upper gastrointestinal endoscopy in a randomly selected, community-based sample of Medicare patients.
DESIGN: We developed a comprehensive and clinically detailed list of 1069 indications for upper gastrointestinal endoscopy. A national panel of nine clinicians rated the appropriateness of the indications. We categorized the indications as appropriate, inappropriate, or equivocal. We did a clinically detailed medical record review of a random sample of 1585 patients having upper gastrointestinal endoscopy to assess the appropriateness of using upper gastrointestinal endoscopy.
SETTING: Patients were sampled from large geographic areas in three states. Two areas represented high use, and one area, low use. PATIENTS: Random sample of patients 65 years of age or older receiving diagnostic upper gastrointestinal endoscopy.
INTERVENTIONS: None; the study was retrospective. MEASUREMENT AND
RESULTS: Patient characteristics, histories, and clinical indications for upper gastrointestinal endoscopy were similar across low- and high-use areas. Overall, 72% of the endoscopies were done for appropriate indications, 11% for equivocal indications, and 17% for inappropriate indications. Upper gastrointestinal bleeding (26%), follow-up to an abnormal upper gastrointestinal series (21%), dysphagia (18%), and dyspepsia (15%) were the most frequent clinical reasons for doing endoscopy. Inpatient endoscopies were more often appropriate and less often inappropriate than outpatient endoscopies.
CONCLUSIONS: This analysis of practice patterns among study sites provides the clinical basis for understanding the use of upper gastrointestinal endoscopy. The finding of 17% inappropriate use may be cause for concern.

Entities:  

Mesh:

Year:  1988        PMID: 3262326     DOI: 10.7326/0003-4819-109-8-664

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  18 in total

1.  Effect of incentives on the use of indicated services in managed care.

Authors:  S Z Pantilat; M Chesney; B Lo
Journal:  West J Med       Date:  1999-03

2.  Management of MRI wait lists in Canada.

Authors:  Derek J Emery; Alan J Forster; Kaveh G Shojania; Stephanie Magnan; Michelle Tubman; Thomas E Feasby
Journal:  Healthc Policy       Date:  2009-02

3.  Management of dyspeptic patients by general practitioners and specialists.

Authors:  V Stanghellini; C Tosetti; G Barbara; B Salvioli; R De Giorgio; R Corinaldesi
Journal:  Gut       Date:  1998-07       Impact factor: 23.059

4.  Is the canadian health care system suffering from abuse? A commentary.

Authors:  C A Woodward; G L Stoddart
Journal:  Can Fam Physician       Date:  1990-02       Impact factor: 3.275

5.  The Drivers of Discretionary Utilization: Clinical History Versus Physician Supply.

Authors:  Gregory W Ruhnke; Willard G Manning; David T Rubin; David O Meltzer
Journal:  Acad Med       Date:  2017-05       Impact factor: 6.893

6.  A systematic approach to the initial evaluation of dyspepsia.

Authors:  K L Kahn
Journal:  J Gen Intern Med       Date:  1989 Sep-Oct       Impact factor: 5.128

7.  Appropriateness in health care delivery: definitions, measurement and policy implications.

Authors:  J N Lavis; G M Anderson
Journal:  CMAJ       Date:  1996-02-01       Impact factor: 8.262

8.  Diagnostic strategies in the management of acute upper gastrointestinal bleeding: patient and physician preferences.

Authors:  J G Dolan; D R Bordley; H Miller
Journal:  J Gen Intern Med       Date:  1993-10       Impact factor: 5.128

Review 9.  The value of endoscopy and endosonography in the diagnosis of the dysphagic patient.

Authors:  R Lorenz; G Jorysz; M Classen
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

Review 10.  The gastroenterologist's approach to dysphagia.

Authors:  R Lorenz; G Jorysz; N Tornieporth; M Classen
Journal:  Dysphagia       Date:  1993       Impact factor: 3.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.